A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Y Yang, D Xin, H Wang, L Guan, X Meng… - Journal of …, 2023 - Taylor & Francis
Purpose Neoadjuvant immunochemotherapy (nICT) for resectable locally advanced
esophageal squamous cell carcinoma (LA-ESCC) has attracted widespread attention …
esophageal squamous cell carcinoma (LA-ESCC) has attracted widespread attention …
Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: a population …
Y Yang, C He - Frontiers in Surgery, 2023 - frontiersin.org
Introduction The development of neoadjuvant chemotherapy (nCT) improves the overall
survival (OS) of patients with esophageal cancer (EC). The aim of this study was to …
survival (OS) of patients with esophageal cancer (EC). The aim of this study was to …
Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment
M Fang, M Chen, X Du, S Chen - Frontiers in Surgery, 2023 - frontiersin.org
Background Neoadjuvant therapy following minimally invasive esophagectomy is
recommended as the standard treatment for locally advanced esophageal squamous …
recommended as the standard treatment for locally advanced esophageal squamous …
[PDF][PDF] Tumor marker index based on CYFRA21-1 and NSE is an important screening index for early-stage esophageal squamous cell carcinoma high-risk groups
M Guo, Y Li, G Lu, S He, M Ren - 2023 - scholar.archive.org
Objective: The purpose of this study was to evaluate a novel tumor marker index (TMI) based
on cytokeratin-19 fragments (CYFRA21-1) and neuron-speci c enolase (NSE) in early-stage …
on cytokeratin-19 fragments (CYFRA21-1) and neuron-speci c enolase (NSE) in early-stage …